Radiotherapy, AdjuvantChemotherapy, AdjuvantCombined Modality TherapyRadiotherapyNeoplasm StagingRadiotherapy DosageTreatment OutcomeNeoplasm Recurrence, LocalRadiotherapy, ConformalRadiotherapy, High-EnergyAdjuvants, ImmunologicMastectomy, SegmentalDisease-Free SurvivalRadiation InjuriesBreast NeoplasmsSurvival RateRadiotherapy, Intensity-ModulatedRadiotherapy Planning, Computer-AssistedRetrospective StudiesRadiodermatitisFollow-Up StudiesPrognosisRectal NeoplasmsSurvival AnalysisMastectomyEpendymomaAntineoplastic Combined Chemotherapy ProtocolsPetrolatumSeminomaFreund's AdjuvantDose FractionationLaryngectomySarcomaCarcinoma, Squamous CellHead and Neck NeoplasmsSpinal Cord NeoplasmsRadiotherapy, Computer-AssistedThymomaRadiotherapy, Image-GuidedThymus NeoplasmsThoracic WallLymphatic MetastasisCarcinoma, Intraductal, NoninfiltratingLymph Node ExcisionBrain NeoplasmsSEER ProgramNeoplasms, Second PrimaryEndometrial NeoplasmsAdenocarcinomaProstatectomyBleomycinSoft Tissue NeoplasmsTime FactorsKaplan-Meier EstimateRadiation OncologyTesticular NeoplasmsDoxorubicinAntineoplastic AgentsBrachytherapyTomography, X-Ray ComputedAdjuvants, PharmaceuticRadiosurgeryDose-Response Relationship, RadiationProspective StudiesProportional Hazards ModelsMultivariate AnalysisNeoplasm InvasivenessFluorouracilNeoplasm MetastasisRandomized Controlled Trials as TopicChemoradiotherapyRecurrenceCisplatinNasopharyngeal NeoplasmsLung NeoplasmsRisk FactorsRadiation ToleranceOrgans at RiskRadiation-Sensitizing AgentsCohort StudiesNeoadjuvant TherapyCranial IrradiationParticle AcceleratorsProstatic NeoplasmsCyclophosphamideVincristineDacarbazineRadiometryRadiation DosageRadiation PneumonitisPelvic NeoplasmsAntineoplastic Agents, HormonalLaryngeal NeoplasmsNeoplasmsHodgkin DiseaseDrug Administration ScheduleNeoplasms, Radiation-InducedProcarbazineAluminum HydroxideHeavy Ion Radiotherapy